Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer

乳腺癌 原发性肿瘤 癌症研究 医学 雌激素受体 病理 癌症 肿瘤科 内科学 生物 细胞培养 转移 遗传学
作者
Adi F. Gazdar,Venkatesh Kurvari,Arvind K. Virmani,Lauren Gollahon,Masahiro Sakaguchi,Max Westerfield,Duli Kodagoda,Victor Stasny,H. Thomas Cunningham,Ignacio I. Wistuba,Gail E. Tomlinson,Vijay S. Tonk,Raheela Ashfaq,A. Marilyn Leitch,John D. Minna,Jerry W. Shay
出处
期刊:International Journal of Cancer [Wiley]
卷期号:78 (6): 766-774 被引量:331
标识
DOI:10.1002/(sici)1097-0215(19981209)78:6<766::aid-ijc15>3.0.co;2-l
摘要

The goal of our study was to develop a panel of tumor cell lines along with paired non-malignant cell lines or strains collected from breast cancers, predominantly primary tumors. From a total of 189 breast tumor samples consisting of 177 primary tumors and 12 metastatic tissues, we established 21 human breast tumor cell lines that included 18 cell lines derived from primary tumors and 3 derived from metastatic lesions. Cell lines included those from patients with germline BRCA1 and FHIT gene mutations and others with possible genetic predisposition. For 19 tumor cell lines, we also established one or more corresponding non-malignant cell strains or B lymphoblastoid (BL) lines, which included 16 BL lines and 7 breast epithelial (2) or stromal (5) cell strains. The present report describes clinical, pathological and molecular information regarding the normal and tumor tissue sources along with relevant personal information and familial medical history. Analysis of the breast tumor cell lines indicated that most of the cell lines had the following features: they were derived from large tumors with or without axillary node metastases; were aneuploid and exhibited a moderate to poorly differentiated phenotype; were estrogen receptor (ER)- and progesterone receptor (PR)-negative; and overexpressed p53 and HER2/neu proteins. Of 13 patients with primary breast cancers receiving curative intent mastectomies, 7 were dead after a mean period of 10 months. Our panel of paired tumor and non-malignant cell lines should provide important new reagents for breast cancer research. Int. J. Cancer 78:766–774, 1998. © 1998 Wiley-Liss, Inc.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
陌语应助科研通管家采纳,获得10
刚刚
SciGPT应助科研通管家采纳,获得10
刚刚
领导范儿应助科研通管家采纳,获得10
刚刚
乐乐应助科研通管家采纳,获得10
刚刚
量子星尘发布了新的文献求助10
刚刚
bkagyin应助科研通管家采纳,获得10
刚刚
科研通AI6应助科研通管家采纳,获得10
刚刚
852应助科研通管家采纳,获得10
刚刚
浮游应助科研通管家采纳,获得10
刚刚
JamesPei应助科研通管家采纳,获得10
刚刚
可爱的函函应助杜大圣采纳,获得10
1秒前
Akim应助科研通管家采纳,获得10
1秒前
所所应助诚心巧凡采纳,获得10
1秒前
1秒前
FashionBoy应助科研通管家采纳,获得20
1秒前
1秒前
1秒前
1秒前
1秒前
Junru完成签到,获得积分10
1秒前
FFF发布了新的文献求助10
2秒前
wyl关注了科研通微信公众号
2秒前
科研通AI6应助一棵白菜采纳,获得10
2秒前
疯尤金完成签到,获得积分10
2秒前
3秒前
共享精神应助小魏采纳,获得10
3秒前
怦然心动发布了新的文献求助10
3秒前
研自助完成签到,获得积分10
4秒前
4秒前
背书强完成签到 ,获得积分10
6秒前
科研助理完成签到 ,获得积分10
6秒前
希望天下0贩的0应助Ikaros采纳,获得10
6秒前
6秒前
6秒前
fei菲飞完成签到,获得积分10
7秒前
科研蜗牛完成签到,获得积分10
7秒前
笑点低诗桃完成签到,获得积分10
7秒前
贾锡政发布了新的文献求助10
8秒前
生动大白菜真实的钥匙完成签到,获得积分10
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Разработка технологических основ обеспечения качества сборки высокоточных узлов газотурбинных двигателей,2000 1000
Optimization and Learning via Stochastic Gradient Search 500
Nuclear Fuel Behaviour under RIA Conditions 500
Why America Can't Retrench (And How it Might) 400
Higher taxa of Basidiomycetes 300
Ricci Solitons in Dimensions 4 and Higher 240
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 催化作用 遗传学 冶金 电极 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 4689158
求助须知:如何正确求助?哪些是违规求助? 4061737
关于积分的说明 12558010
捐赠科研通 3759159
什么是DOI,文献DOI怎么找? 2076091
邀请新用户注册赠送积分活动 1104760
科研通“疑难数据库(出版商)”最低求助积分说明 983769